Related Experiment Video
Updated: Jun 12, 2026
07:44
Establishment of Orthotopic Patient-derived Xenograft Models for Brain Tumors using a Stereotaxic Device
Published on: May 2, 2025
Approved Targeted Treatments for Pediatric Brain Tumors
Eric Bouffet1, David Neal Franz2,3, Isabel Arrillaga-Romany4
1Neuro-Oncology Section, The Hospital for Sick Children, University of Toronto, Toronto, Canada.
Summary
Targeted therapies are revolutionizing pediatric brain tumor treatment by focusing on specific genetic changes. While promising, challenges remain in clinical trials, treatment duration, resistance, and global access to these advanced therapies.
Area of Science:
- Pediatric Neuro-Oncology
- Molecular Diagnostics
- Genomic Techniques
Background:
- Molecular and genomic advances have enhanced understanding of pediatric brain tumors.
- Targeted therapies are emerging for specific genetic alterations, improving treatment efficacy and reducing toxicity.
Purpose of the Study:
- To review the clinical development and regulatory approval of targeted therapies for pediatric brain tumors.
- To address challenges in pediatric clinical trials and unresolved questions regarding treatment.
Main Methods:
- Review of clinical development and regulatory approval data for targeted therapies.
- Analysis of challenges in pediatric clinical trial design and conduct.
- Discussion of unresolved issues and global access to therapies.
Main Results:
- Several targeted agents approved, particularly for MAP kinase pathway alterations.
- Molecular diagnostics integration is crucial for routine care.
- Significant challenges exist in pediatric clinical trials, including small patient numbers.
Conclusions:
- Targeted therapies represent a paradigm shift in pediatric neuro-oncology, offering personalized treatment.
- Further research is needed to address treatment duration, resistance, and long-term effects.
- Ensuring equitable global access to these costly therapies is a critical challenge.
Related Concept Videos
02:57Targeted Cancer Therapies
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
There are several types of targeted therapies against specific...
02:57Targeted Cancer Therapies
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
There are several types of targeted therapies against specific...
02:50Combination Therapies and Personalized Medicine
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...